Palau Science & Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palau Science & Technology Journal.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 5, 2026

January 5, 2026

Premium Portraits Launches AI Platform for Professional Business Headshots from Selfies

GlobeNewswire

January 5, 2026

캐딜락 에스컬레이드 IQ, ‘2026 모터트렌드 SUV 오브 더 이어’로 선정되며 Altia의 HMI 기술력 부각

GlobeNewswire

January 5, 2026

Cerence xUI, Leveraging NVIDIA AI Enterprise and Running on Microsoft Azure, Drives Strong Traction with Automakers

GlobeNewswire

January 5, 2026

HP at CES 2026 — HP Drives the Next Chapter of Intelligent Work

GlobeNewswire

January 5, 2026

NVIDIA Kicks Off the Next Generation of AI With Rubin — Six New Chips, One Incredible AI Supercomputer

GlobeNewswire

January 5, 2026

NVIDIA Releases New Physical AI Models as Global Partners Unveil Next-Generation Robots

GlobeNewswire

January 5, 2026

Alumis to Host Conference Call and Webcast to Report Phase 3 ONWARD Topline Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis

GlobeNewswire

January 5, 2026

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026

GlobeNewswire

January 5, 2026

Microchip Technology Provides Q3 Fiscal 2026 Business Update

GlobeNewswire

January 5, 2026

Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

3D Systems to Present at the Needham Growth Conference

GlobeNewswire

January 5, 2026

Bel Fuse Announces Participation in the 28th Annual Needham Growth Conference

GlobeNewswire

January 5, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

January 5, 2026

Zscaler Appoints Sunil Frida as Chief Marketing Officer to Drive Next Phase of Global Growth

GlobeNewswire

January 5, 2026

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

GlobeNewswire

January 5, 2026

Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities

GlobeNewswire

January 5, 2026

Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1b Trial of APG777 in Patients with Mild-to-Moderate Asthma and 2026 Anticipated Milestones on January 6, 2026

GlobeNewswire

January 5, 2026

Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression

GlobeNewswire

January 5, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire